RESEARCH ARTICLE
Novel Approaches for Treating Musculoskeletal Diseases: Molecular Orthopedics and Systems Medicine
Kaveh Mashayekhi 1, 2, 3, Margaret O’Brien 4, Florin Zugun-Eloae 5, Luminita Labusca *, 1, 6
Article Information
Identifiers and Pagination:
Year: 2013Volume: 7
Issue: Suppl 1
First Page: 144
Last Page: 151
Publisher ID: TOORTHJ-7-144
DOI: 10.2174/1874325001307010144
Article History:
Received Date: 15/12/2012Revision Received Date: 25/1/2013
Acceptance Date: 2/2/2012
Electronic publication date: 3 /5/2013
Collection year: 2013
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Molecular medicine uses knowledge about cell structure and function for disease, diagnostics, stage characterisation and treatment. The advent of genomic technologies is considerably leading to developments in the field of molecular medicine. The accumulation of detailed information about gene expression, epigenetic variability, protein transcription and functional modulation is contributing to a new era in medicine. Rapid and early diagnostic procedures, molecular characterisation of degenerative and proliferative diseases and personalized therapies are predicted to lead to advancements in health prevention and treatment of disease. Diagnostic tools and therapies based on local and /or general modulation of cellular processes for traumatic or degenerative musculoskeletal conditions are becoming available. A logical consequence of the information derived from extensive data gathering, systems biology and systemic medicine has lead to significant improvements in understanding biological structure and function in a simultaneous bottom top and integrative, holistic manner. The description of disease mechanism at an intimate, subcellular level has a dual benefit. A thorough understanding of the crosstalk involved in molecular pathways both in the normal and the diseased state are expanding scientific knowledge and simultaneously are enabling design cell-targeted and individualized therapies. This paper presents a brief overview of current molecular based treatments available to the orthopedic surgeon and introduces the concept of systemic medicine from the perspective of musculoskeletal pathology.
